Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys

Neurobiology of Disease

Volumn 23, Issue 2, 2006, Pages 471-480

  Emerich, Dwaine F ^a   Thanos, Christopher G ^a   Goddard, Moses ^a   Skinner, Stephen J M ^b   Geany, Marilyn S ^b   Bell, William J ^a   Bintz, Briannan ^a   Schneider, Patricia ^a   Chu, Yaping ^c   Babu, Rangasamy Suresh ^c   Borlongan, Cesario V ^d   Boekelheide, Kim ^e   Hall, Susan ^e   Bryant, Bronwyn ^e   Kordower, Jeffrey H ^c  

^a LCT BioPharma Inc   (United States)

^b Living Cell Technologies NZ Ltd   (New Zealand)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

Alginate; Choroid plexus; CNS transplantation; Encapsulation; Neuroprotection

Indexed keywords

ALGINIC ACID; EXCITOTOXIN; PREALBUMIN; PROTEIN ZO1; QUINOLINIC ACID; TUBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN NERVE CELL; BRAIN TRANSPLANTATION; CAUDATE NUCLEUS; CELL COUNT; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CHOROID PLEXUS; CONTROLLED STUDY; CORPUS STRIATUM; ENCAPSULATION; IMMUNOCYTOCHEMISTRY; NERVE DEGENERATION; NEURITE; NEUROPROTECTION; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; STAINING; STEREOMETRY; SWINE;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CHOROID PLEXUS; DISEASE MODELS, ANIMAL; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; RATS; SWINE;

EID: 33746268578     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.04.014     Document Type: Article

References (62)

1. Aebischer P., Tresco P.A., Sagen J., and Winn S.R. Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats. Brain Res. 560 (1991) 43-49
2. Alberch J., Perez-Navarro E., and Canals J.M. Neurotrophic factors in Huntington's disease. Prog. Brain Res. 146 (2004) 195-229
3. Araujo D.M., and Hilt D. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease. Neuroscience 81 (1997) 1099-1110
4. Araujo D.M., and Hilt D.C. Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid. Neuroscience 82 (1998) 117-127
5. Borlongan C.V., Skinner S.J.M., Geaney M., Vasconcellos A., Elliott R., and Emerich D.F. Intracerebral transplantation of porcine choroid plexus provides structural and functional neuroprotection in a rodent model of stroke. Stroke 35 (2004) 2206-2210
6. Borlongan C.V., Skinner S.J.M., Geaney M., Vasconcellos A., Elliott R., and Emerich D.F. CNS grafts of rat choroid plexus protect against cerebral ischemia in adult rats. NeuroReport 15 (2004) 1543-1547
7. Borlongan C.V., Skinner S.J.M., Geaney M., Vasconcellos A., Elliott R.B., Skinner S.S., and Emerich D.F. Neuroprotection by encapsulated choroid plexus in a rodent model of Huntington's disease. NeuroReport 15 (2004) 2521-2525
8. Cavalieri B. Geometri degli indivisibli Tornio, Unione Tipografico, Editrice (1966) 1-543
9. Chodobski A., and Szmydynger-Chodobska J. Choroid plexus: target for polypeptides and site of their synthesis. Microsc. Res. Tech. 52 (2001) 65-82
10. Chu Y., Kompoliti K., Cochran E.J., Mufson E.J., and Kordower J.H. Age-related decreases in Nurr1 immunoreactivity in the human SN. J. Comp. Neurol. 450 (2002) 203-214
11. Conneally P.M., Wallace M.R., Gusella J.F., and Wexler N.S. Huntington's disease: estimation of heterozygote status using linked genetic markers. Genet. Epidemiol. 1 (1984) 81-88
12. Davies S.W., and Beardsall K. Nerve growth factor selectively prevents excitotoxin-induced degeneration of striatal cholinergic neurones. Neurosci. Lett. 140 (1992) 161-164
13. de Almeida L.P., Zala D., Aebischer P., and Deglon N. Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease. Neurobiol. Dis. 8 (2001) 433-446
14. Emerich D.F. Neuroprotection in Huntington's Disease. Expert Opin. Biol. Ther. 1 (2001) 467-479
15. Emerich D.F., Winn S.R., Lindner M.D., Frydel B.R., and Kordower J.H. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease. J. Neurosci. 16 (1996) 5168-5181
16. Emerich D.F., Winn S.R., Chen E.Y., Chu Y., McDermott P., Baetge E., and Kordower J.H. Protection of basal ganglia circuitry by encapsulated CNTF-producing cells in a primate model of Huntington's disease. Nature 386 (1997) 395-399
17. Emerich D.F., Vasconcellos A., Elliott R.B., Skinner S.J.M., and Borlongan C.V. The Choroid plexus: function, pathology and therapeutic potential of its transplantation. Expert Opin. Biol. Ther. 4 (2004) 1191-1201
18. Emerich D.F., Skinner S.J.M., Borlongan C.V., Vasconcellos A., and Thanos C.G. The choroid plexus in the rise, fall, and repair of the brain. BioEssays 27 (2005) 262-274
19. Fan M.Y., Lum Z.P., Fu X.W., Levesque L., Tai I.T., and Sun A.M. Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes 39 (1990) 519-522
20. Ferrand-Drake M. Cell death in the choroid plexus following transient forebrain global ischemia in the rat. Microsc. Res. Tech. 52 (2001) 130-136
21. Fienberg A.A., and Greengard P. The DARPP-32 knockout mouse. Brain Res. Brain Res. Rev. 2-3 (2000) 313-319
22. Fritschy W.M., Wolters G.H., and van Schilfgaarde R. Effect of alginate-polylysine-alginate microencapsulation on in vitro insulin release from rat pancreatic islets. Diabetes 40 (1991) 37-43
23. Garcia-Martin C., Chuah M.K., Van Damme A., Robinson K.E., Vanzieleghem B., and Saint-Remy J.M. Therapeutic levels of human factor VIII in mice implanted with encapsulated cells: potential for gene therapy of haemophilia A. J. Gene Med. 4 (2002) 215-223
24. George P., Xu-Feng H., and Arthur W.T. The Rhesus Monkey Brain in Stereotaxic Coordinates (2000), Academic Press, New York
25. Gratacos E., Perez-Navarro E., Tolosa E., Arenas E., and Alberch J. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members. J. Neurochem. 78 (2001) 1287-1296
26. Greenamyre J.T., and Shoulson I. Huntington's disease. In: Calne D. (Ed). Neurodegenerative Diseases (1994), Saunders Press, Inc., Philadelphia PA 685-704
27. Greengard P. The neurobiology of dopamine signaling. Biosci. Rep. 3 (2001) 247-269
28. Gunderson H., and Jensen E.B. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 147 (1987) 229-263
29. Hortelano G., Al-Hendy A., Ofosu F.A., and Chang P.L. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood 87 (1996) 5095-5103
30. Ide C., Kitada M., Chakrabortty S., Taketomi M., Matsumoto N., Kikukawa S., Mizoguchi A., Kawaguchi S., Endoh K., and Suzuki Y. Grafting of choroid plexus ependymal cells promotes the growth of regenerating axons in the dorsal funiculus of rat spinal cord: a preliminary report. Exp. Neurol. 167 (2001) 242-251
31. Kells A.P., Fong D.M., Dragunow M., During M.J., Young D., and Conor B. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a mouse model of Huntington disease. Mol. Ther. 9 (2004) 682-688
32. Kimura K., Matsumoto N., Kitade M., Mizoguchi A., and Ide C. Neurite outgrowth from hippocampal neurons is promoted by choroid plexus ependymal cell in vitro. J. Neurocytol. 33 (2004) 465-476
33. Korbutt G.S., Mallett A.G., Ao Z., Flashner M., and Rajotte R.V. Improved survival of microencapsulated islets during in vitro culture and enhanced metabolic function following transplantation. Diabetologia 47 (2004) 1810-1818
34. Kordower J.H., Isacson O., and Emerich D.F. Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible?. Exp. Neurol. 159 (1999) 4-20
35. Kordower J.H., Chu Y., Stebbins G.T., DeKosky S.T., Cochran E.J., Bennett D., and Mufson E.J. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann. Neurol. 49 (2001) 202-213
36. Leung Y.F., O'Shea G.M., Goosen M.F., and Sun A.M. Microencapsulation of crystalline insulin or islets of Langerhans: an insulin diffusion study. Artif. Organs 7 (1983) 208-212
37. Li S.H., Cheng A.L., Li H., and Li X.J. Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin. J. Neurosci. 19 (1999) 5159-5172
38. Maysinger D., Piccardo P., Filipovic-Grcic J., and Cuello A.C. Microencapsulation of genetically engineered fibroblasts secreting nerve growth factor. Neurochem. Int. 23 (1993) 123-129
39. Maysinger D., Piccardo P., Liberini P., Jalsenjak I., and Cuello C. Encapsulated genetically engineered fibroblasts: release of nerve growth factor and effects in vivo on recovery of cholinergic markers after devascularizing cortical lesions. Neurochem. Int. 24 (1994) 495-503
40. McBride J.L., During M.J., Wu J., Chen E.Y., Leurgans S.E., and Kordower J.H. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. Exp. Neurol. 181 (2003) 213-223
41. Menei P., Pean J.M., Nerriere-Daguin V., Jollivet C., Brachet P., and Benoit J.P. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage. Exp. Neurol. 161 (2000) 259-272
42. Mittoux V., Joseph J.M., Conde F., Palfi S., Dautry C., Poyot T., Bloch J., Deglon N., Ouary S., Nimchinsky E.A., Brouillet E., Hof P.R., Peschanski M., Aebischer P., and Hantraye P. Restoration of cognitive and motor function with ciliary neurotrophic factor in a primate model of Huntington's disease. Hum. Gene. Ther. 11 (2000) 1177-1187
43. Perez-Navarro E., Arenas E., Reiriz J., Calvo N., and Alberch J. Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from exitotoxic damage. Neuroscience 75 (1996) 345-352
44. Perez-Navarro E., Arenas E., Marco S., and Alberch J. Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo. Eur. J. Neurosci. 11 (1999) 241-249
45. Perez-Navarro E., Canudas A.M., Akerund P., Alberch J., and Arenas E. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease. J. Neurochem. 75 (2000) 2190-2199
46. Preston J.E. Ageing choroid plexus-cerebrospinal fluid system. Microsc. Res. Tech. 52 (2001) 31-37
47. Ross C.J., and Chang P.L. Development of small alginate microcapsules for recombinant gene product delivery to the rodent brain. J. Biomater. Sci., Polym. Ed. 13 (2002) 953-962
48. Safford K.M., Hicok K.C., Safford S.D., Halvorsen Y.D., Wilkison W.O., Gimble J.M., and Rice H.E. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem. Biophys. Res. Commun. 294 (2002) 371-379
49. Schmitz C., and Hof P.R. Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach. J. Chem. Neuroanat. 20 (2000) 93-114
50. Serot J.M., Bene M.C., and Faure G.C. Choroid plexus, ageing of the brain, and Alzheimer's disease. Front. Biosci. 8 (2003) 515-521
51. Shoulson I. Huntington's disease: functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 31 (1981) 1333-1335
52. Stopa E.G., Berzin T.M., Kim S., Song P., Kuo-Leblanc V., Rodriguez-Wolf M., Baird A., and Johanson C.E. Human choroid plexus growth factors: what are the implications for CSF dynamics in Alzheimer's disease. Exp. Neurol. 167 (2001) 40-47
53. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-978
54. Tresco P.A., Winn S.R., and Aebischer P. Polymer encapsulated neurotransmitter secreting cells. Potential treatment for Parkinson's disease. ASAIO J. 38 (1992) 17-23
55. Visted T., Bjerkvig R., and Enger P.O. Cell encapsulation technology as a therapeutic strategy for CNS malignancies. Neuro-oncology 3 (2001) 201-210
56. Wang T., Lacik I., Brissova M., Anilkumar A.V., and Prokop A. An encapsulation system for the immunoisolation of pancreatic islets. Nat. Biotechnol. 15 (1997) 358-362
57. Watanabe Y., Matsumoto N., Dezawa M., Itokazu Y., Yoshihara T., and Ide C. Conditioned medium of the primary culture of rat choroid plexus epithelial (modified ependymal) cells enhance neurite outgrowth and survival of hippocampal neurons. Neurosci. Lett. 379 (2005) 158-163
58. Weisner B., and Roethig H.J. The concentration of prealbumin in cerebrospinal fluid (CSF), indicator of CSF circulation disorders. Eur. Neurol. 55 (1983) 96-105
59. West M.J., Slomianka L., and Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231 (1991) 482-497
60. Winn S.R., Tresco P.A., Zielinski B., Greene L.A., Jaeger C.B., and Aebischer P. Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells. Exp. Neurol. 113 (1991) 322-329
61. Wolf H.K., Buslei R., Schmidt-Kastner R., Schmidt-Kastner P.K., and Pietsch T. NeuN: a useful neuronal marker for diagnostic histopathology. J. Histochem. Cytochem. 44 (1996) 1167-1171
62. Xue Y., Gao J., Xi Z., Wang Z., Li X., and Cui X. Microencapsulated bovine chromaffin cell xenografts into hemiparkinsonian rats: a drug-induced rotational behavior and histological changes analysis. Artif. Organs 25 (2001) 131-135